1st Quarter - Report

MARSHALL & POPP, LLC for GENENTECH, INC.

Period 1st Quarter 2019 Filed Apr 22, 2019 Signed by Beth Anne Cole

Official filing
Firm
MARSHALL & POPP, LLC
Client
GENENTECH, INC.
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription drug value issues. Biosimilars. Importation of prescription drugs. 340B issues. FDA regulatory issues, including the International Pricing Index and Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL Policy Director, Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant, Senator Don Nickles
MONICA POPP Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Office of the Vice President of the United States; White House Office; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.